RXO (NYSE:RXO) reported quarterly losses of $(0.03) per share which missed the analyst consensus estimate of $(0.02) by 50 percent. This is unchanged from the same period last year. The company reported quarterly sales of $1.43 billion which missed the analyst consensus estimate of $1.49 billion by 4.06 percent. This is a 56.96 percent increase over sales of $913.00 million the same period last year.